Your Health, We Care
Most common adverse reactions (≥5%) are peripheral edema, hypotension (including orthostatic hypotension), dizziness, hyperkalemia, and anemia.
from FDA，2023.02
During treatment with Sparsentan, regular monitoring is required. Follow-up shou···【more】
Release date：2026-03-18Recommended：52
